ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 139 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,698,000 | +6480.5% | 447,447 | +3839.1% | 0.00% | – |
| Q3 2019 | $41,000 | -47.4% | 11,359 | -61.2% | 0.00% | – |
| Q2 2019 | $78,000 | -19.6% | 29,273 | +11.5% | 0.00% | – |
| Q3 2018 | $97,000 | +4.3% | 26,265 | +29.5% | 0.00% | – |
| Q2 2017 | $93,000 | +31.0% | 20,280 | +19.7% | 0.00% | – |
| Q1 2017 | $71,000 | -78.5% | 16,943 | -60.3% | 0.00% | -100.0% |
| Q1 2016 | $330,000 | -26.5% | 42,728 | +2.7% | 0.00% | -50.0% |
| Q4 2015 | $449,000 | -70.1% | 41,620 | -75.5% | 0.00% | -80.0% |
| Q2 2015 | $1,503,000 | +126.4% | 169,633 | +213.0% | 0.01% | +100.0% |
| Q4 2014 | $664,000 | +118.4% | 54,200 | +78.0% | 0.01% | +66.7% |
| Q3 2014 | $304,000 | – | 30,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |